Lenvatinib is primarily used to manage a range of cancers, including thyroid cancer, kidney cancer, liver cancer, and endometrial cancer. It belongs to the group of tyrosine kinase inhibitors.
High blood pressure
Diarrhoea
Fatigue
Decreased appetite
Nausea and vomiting
Lenvatinib is a type of medicine known as a tyrosine kinase inhibitor.
It works by blocking the action of specific enzymes called tyrosine kinases. These enzymes play a key role in promoting the growth and spread of cancer cells. By blocking these enzymes, Lenvatinib interrupts the growth and proliferation of cancer cells, helping to slow down or halt their spread within the body.
BDS, MDS
BMS, FMC, MD Resident
Lenvatinib can be taken orally (capsule).
Lenvatinib is approved for use in adults.
Lenvatinib is contraindicated for individuals who have shown hypersensitivity to the active ingredient, Lenvatinib, or any other ingredients in the capsule.
This medicine may interact with strong antifungals (such as ketoconazole and itraconazole) and antibiotics (like rifampicin and phenytoin).
There is no specific antidote for Lenvatinib overdose. In case of suspected overdose, supportive care should be provided as necessary.
If you miss a dose of Lenvatinib, you should take it as soon as possible. However, if it is less than 12 hours until your next scheduled dose, then you should skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
Drinking plenty of water may help manage some side effects like diarrhoea.
Resting or reducing physical activity may help manage fatigue.
Drinking cool water may help manage stomatitis (mouth sores).
Lenvatinib may cause fatigue and dizziness, which could affect your ability to drive or operate machinery. It is advisable to avoid such activities if you experience these side effects.
Lenvatinib can cause harm to the foetus and is not recommended for use during pregnancy. It is not known if Lenvatinib is excreted in human milk. Breastfeeding should be discontinued during treatment and for at least one week after the last dose. Lactating mothers should consult with their doctor before starting the medication.
Caution should be exercised while administering Lenvatinib to patients with severe renal impairment or hepatic impairment, as its safety and effectiveness in these conditions are not well-established.
Patients with a history of hypertension, heart disease, or kidney problems should be closely monitored when taking this medication.
Regular mild exercise can help improve the physical stamina of patients.
Regular follow-ups with the doctor are necessary to monitor the progress of treatment.
Frequently asked questions
No, Lenvatinib is not a steroid. It is a medication that belongs to the class known as tyrosine kinase inhibitors, used for managing certain types of cancer.
Lenvatinib is not known to cause sleep disturbances as a side effect of Lenvatinib. However, fatigue is a common side effect which could potentially impact your sleep. Consult your doctor if you experience any sleep-related issues while on this medication.
As per the research data, women of childbearing potential are advised to use effective contraception during treatment and for at least 30 days after the last dose, as Lenvatinib can cause harm to the fetus. However, there is no specific mention of Lenvatinib affecting fertility.
Yes, it is safe to take Lenvatinib daily if it is prescribed by your doctor. The doctor will determine the correct dosage based on your condition and response to treatment.
The time it takes for Lenvatinib to show effects can vary among individuals, and some may see improvements within a few weeks while others may take several months. Regular follow-ups with your doctor are important to monitor progress and adjust treatment as necessary.
The duration of treatment with Lenvatinib depends on your condition and how your body responds to the medication. Your doctor will decide the duration of treatment based on these factors.
The safety of long-term use of Lenvatinib is determined by your doctor based on your individual health condition and response to the medicine. It is important to regularly consult your doctor during your treatment with Lenvatinib.
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.16
Our Payment Partners